Literature DB >> 20813385

Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.

G K Wenning1, C Colosimo.   

Abstract

The atypical parkinsonian disorders (APD) embrace a heterogeneous group of movement disorders all characterized by prominent parkinsonism, accompanied by specific additional features such as cerebellar ataxia, early autonomic dysfunction, early dementia, pyramidal tract signs, myoclonus, supranuclear gaze palsy, apraxia which are atypical for idiopathic Parkinson's disease (PD). Beside these features, rapid disease progression and poor or absent response to L-Dopa therapy both raise the suspicion of an APD. Currently, multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and dementia with Lewy bodies (DLB) are referred to as APD. Clinical diagnosis can be difficult in early stages and although the predictive value of the widely established, diagnostic criteria is high at first neurological evaluation sensitivity tends to be poor and may be less than 30%. In this review, we will discuss diagnostic issues in MSA and PSP.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20813385     DOI: 10.1016/j.neurol.2010.07.004

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  8 in total

1.  Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature.

Authors:  QuanZhen Zhao; Xinglong Yang; SiJia Tian; Ran An; JinHua Zheng; Yanming Xu
Journal:  Neurol Sci       Date:  2015-11-21       Impact factor: 3.307

2.  Degeneration of brainstem respiratory neurons in dementia with Lewy bodies.

Authors:  Michael F Presti; Ann M Schmeichel; Phillip A Low; Joseph E Parisi; Eduardo E Benarroch
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

3.  Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Authors:  Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

Review 4.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

5.  α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.

Authors:  Verena E L May; Benjamin Ettle; Anne-Maria Poehler; Silke Nuber; Kiren Ubhi; Edward Rockenstein; Beate Winner; Michael Wegner; Eliezer Masliah; Jürgen Winkler
Journal:  Neurobiol Aging       Date:  2014-03-04       Impact factor: 4.673

6.  Extending the range of differential diagnosis of chronic traumatic encephalopathy of the boxer: Insights from a case report.

Authors:  Leonardo Caixeta; Iron Dangoni; Rafael Dias de Sousa; Pedro Paulo Dias Soares; Andreia Costa Rabelo Mendonça
Journal:  Dement Neuropsychol       Date:  2018 Jan-Mar

7.  Discriminative pattern of reduced cerebral blood flow in Parkinson's disease and Parkinsonism-Plus syndrome: an ASL-MRI study.

Authors:  Lina Cheng; Xiaoyan Wu; Ruomi Guo; Yuzhou Wang; Wensheng Wang; Peng He; Hanbo Lin; Jun Shen
Journal:  BMC Med Imaging       Date:  2020-07-13       Impact factor: 1.930

8.  A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson's disease, multiple system atrophy and healthy control.

Authors:  F Nemmi; A Pavy-Le Traon; O R Phillips; M Galitzky; W G Meissner; O Rascol; P Péran
Journal:  Neuroimage Clin       Date:  2019-05-13       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.